相关实验视频

Updated: May 22, 2025

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model

Published on: June 11, 2020

癌症治疗的mRNA传递系统的最新进展

Zheng Zhang¹, Ya-Nan Fan¹, Si-Qi Jiang¹

¹School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou, 511442, P. R. China.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

|May 20, 2025

概括

使者RNA (mRNA) 疗法在瘤学中显示出疫苗和治疗的前景. 传递系统的进步是克服mRNA稳定性和针对改善癌症治疗的挑战的关键.

科学领域:

在瘤学瘤学.
生物技术是生物技术.
纳米医学是一种纳米医学.

背景情况:

使者RNA (mRNA) 疗法在瘤学中提供了创新的应用,包括瘤疫苗,蛋白质替代,细胞和基因疗法.
在mRNA治疗方面仍然存在重大挑战,主要是关于mRNA稳定性和有效地传递到目标部位.
克服这些障碍对于提高基于mRNA的癌症治疗的安全性和有效性至关重要.

研究的目的:

审查mRNA治疗在瘤学中的多样化应用.
探索非病毒载体 (有机,无机,仿生) 在mRNA传递中的作用和类型.
讨论针对性策略,刺激响应系统和mRNA治疗的非侵入性施用途径的进展.

主要方法:

关于瘤学中mRNA疗法的当前研究的文献综述.
对mRNA输送的非病毒载体系统的分析,包括向机制.
检查刺激反应和非侵入性输送策略 (口服,肺部).

主要成果:

非病毒载体,包括有机,无机和仿生系统,对于有效的mRNA传递至关重要.
被动和主动准策略,以及对刺激有反应的系统 (pH,超声波),提高了精度.
开发用于口服和肺部的非侵入性输送系统取得了显著进展.

结论:

传递系统的进步对于实现mRNA治疗在瘤学中的全部潜力至关重要.
针对性,刺激反应和非侵入性输送方法是改善治疗结果的关键.
应对当前的挑战和接受新兴趋势将推动基于mRNA的癌症治疗的未来.

关键词:

生物材料是一种生物材料.癌症免疫疗法癌症免疫疗法癌症治疗方法癌症治疗方法系统交付系统的交付系统.它们是mRNARNA.

更多相关视频

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Regulated mRNA Transport

Regulated mRNA Transport

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...